MIRA INFORM REPORT

 

 

Report Date :

11.09.2014

 

IDENTIFICATION DETAILS

 

Name :

WALLACE PHARMACEUTICALS PRIVATE LIMITED [w.e.f. 31.08.2001]

 

 

Formerly Known As :

WALLACE PHARMACEUTICALS LIMITED

 

 

Registered Office :

3rd Floor, Dempo Trade Centre Building, Patto Plaza, EDC Complex, Panaji-403001, Goa

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

02.02.1998

 

 

Com. Reg. No.:

24-000080

 

 

Capital Investment / Paid-up Capital :

Rs.51.450 Millions

 

 

CIN No.:

[Company Identification No.]

U24239GA1968PTC000080

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

BLRW00502F

 

 

PAN No.:

[Permanent Account No.]

AAACW1667Q

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Subject is engaged in the manufacturing and selling of medicinal preparations.

 

 

No. of Employees :

Information decline by the management

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (49)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct

 

 

Litigation :

Exists

 

 

Comments :

Subject is an established company having satisfactory track.

 

Financial position of the company seems to be decent.

 

Trade relations are fair. Business is active. Payment terms are reported to be usually correct.

 

The company can be considered normal or business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

INDIAN ECONOMIC OVERVIEW

 

N E W S

 

As per the latest IMF study, the total weigh of emerging markets in the GDP of the world on a purchasing power parity basis has seen a sizeable shift. It highlights how as against 51 % in 2005, the emerging economies now account for close to 56 % of the global purchasing power GDP as per the latest survey. And with the emerging economies growing at a faster rate than their developed counterparts, there are every possibility that the their share goes up further in the coming years.  China may surpass the US over the next few years.

 

Politics and economics are very intricately connected. They tend to influence each other in ways that could be very complex and far-reaching. The prospects of the India’s economy have been seriously compromised due to political corruption. High inflation, poor standard of living are to a great extent a result of rampant corruption in the country. China on the other hand, seems to be facing diametrically opposite challenge. American hedge fund manager Jim Chanos has been keenly following the political and economic development in the dragon economy and has figured out something that is quite worrying. He is of the view that the Chinese economy could be heading toward trouble on account of new Chinese President Xi Jingping’s very aggressive anti-corruption drive. Chanos believes tat many things such as apartment sales, luxury products, etc. were largely bought with dirty money. And it is now beginning to impact consumption. This may indeed be bad news for an economy that is struggling to transition from an investment-driven export-oriented economy to a domestic consumption-driven economy.

 

A study published by Firstpost has revealed that asset classes like real estate and equities were the biggest beneficiaries of the liberalization policies.  A firm called Ciane Analytics studied returns from assets including equities, gold, fixed deposits, G-Secs and real estate since 1991. Real estate outperformed every other asset classes during the 23-year period with an annualized return of 20 % ! Equities came in second with annualized return of 15.5 % ! However, while these returns may seem mouthwatering, the fact is that the return from equities adjusted for inflation came down to just 7.1 %.

 

Some brief news are as under

. R-Power to buy Jaypee’s hydro assets

. Investors await justice in NSEL case

. India seeks MFN status from Pakistan ahead of meeting

. Ukrain’s clashes with rebels hinder MH17 crash investigation

. India exploring merger of state-owned hydro PSUs

..Higher costs weigh down profit growth to slowest in 9 quarters

..Wal-Mart to expand wholesale business in India

. GMR group moves to strengthen balance sheet

. Central Bank to sell 4 % stake to Life Insurance Corporation

. Tata Chemicals plans to raise up to Rs 10000 mn.

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CRISIL

Rating

Long term rating: BBB

Rating Explanation

Have moderate degree of safety and carry moderate credit risk.

Date

27.06.2014

 

Rating Agency Name

CRISIL

Rating

Short term rating: A3+

Rating Explanation

Have moderate degree of safety and carry higher credit risk.

Date

27.06.2014

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

INFORMATION DECLINED

 

MANAGEMENT NON – COOPERATIVE (91-832-2438156)

 

LOCATIONS

 

Registered Office/ Headquarter :

3rd Floor, Dempo Trade Centre Building, Patto Plaza, EDC Complex, Panaji-403001, Goa, India 

Tel. No.:

91-832-2438156/7/8/9/60/61

Fax No.:

91-832-2438151

E-Mail :

cesarmenezes@wallacepharma.net

wallacehogoa@wallacepharma.net

partnership@wallacepharma.net

international@wallacepharma.net 

 

 

Marketing and Sales Office :

B-307/312, Floral Deck Plaza, Off Central Central, MIDC Road, Andheri (East), Mumbai-400093, Maharashtra, India

Tel. No.:

91-22-28390681/2/3

Fax No.:

91-22-28390733

 

 

DIRECTORS

 

As on 10.09.2013

 

Name :

Mr. Cesar Pascoal Jose Menezes

Designation :

Chairman cum Managing Director

Address :

C-22, H. No. 304, Vainguinim Valley, Dona Paula-403004, Goa, India

Date of Birth/Age :

14.10.1943

PAN No.:

ACLPM6506G

Date of Appointment :

15.06.2005

DIN No.:

00407272

 

 

Name :

Dr. Maria Emilia Menezes

Designation :

Director

Address :

C-22, H. No. 304, Vainguinim Valley, Dona Paula-403004, Goa, India

Date of Birth/Age :

08.11.1946

PAN No.:

AABTM1709K

Date of Appointment :

09.12.1997

DIN No.:

00419902

 

 

Name :

Mrs. Rashmi Cesar Menezes

Designation :

Director

Address :

10, Vin-Rita Apartments, Opposite Prof Almeida Park, Bandra, Mumbai-400050, Maharashtra, India

Date of Birth/Age :

25.07.1974

PAN No.:

ADKPM5014B

Date of Appointment :

31.05.2001

DIN No.:

01006018

 

 

Name :

Ms. Divya Cesar Menezes

Designation :

Director

Address :

26, Windmere, BJ Road, Bandra, Mumbai-400050, Maharashtra, India

Date of Birth/Age :

28.07.1971

PAN No.:

ACZPM9041J

Date of Appointment :

25.02.2002

DIN No.:

01854660

 

 

Name :

Mr. Vinay Pinto

Designation :

Director

Address :

10, Vin-Rita Apartments, Opposite Prof Almeida Park, Bandra, Mumbai-400050, Maharashtra, India

Date of Birth/Age :

31.03.1971

PAN No.:

AAJPP1095K

Date of Appointment :

25.02.2002

DIN No.:

01005975

 

 

Name :

Mr. Karl Pinto

Designation :

Director

Address :

26, Windmere, BJ Road, Bandra, Mumbai-400050, Maharashtra, India

Date of Birth/Age :

17.01.1970

PAN No.:

AKAPP0562E

Date of Appointment :

29.07.2005

DIN No.:

01201333

 

 

Name :

Mr. Naveen Chamanlal Gupta

Designation :

Director

Address :

H. No. 6705, GH-4A, Jalvayu Vihar, Sector 20, Panchkula-134109, Haryana, India

Date of Birth/Age :

20.04.1972

PAN No.:

AEQPG5981G

Date of Appointment :

27.05.2011

DIN No.:

03534115

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 10.09.2013

 

Names of Shareholders

 

No. of Shares

Cesar Pascoal Jose Menezes

 

2625000

Maria Emilia Menezes

 

560000

Divya Cesar Menezes

 

980000

Rashmi Cesar Menezes

 

979900

Rekha Charvdatt Daru

 

100

Total

 

5145000

 

Equity Share Break up (Percentage of Total Equity)

 

As on 10.09.2013

 

Category

Percentage

Directors or relatives of Directors

100.00

Total

100.00

 

 

BUSINESS DETAILS

 

 

Line of Business :

Subject is engaged in the manufacturing and selling of medicinal preparations.

 

 

PRODUCTION STATUS [AS ON 31.03.2012]

 

PARTICULARS

Unit

Installed Capacity on Single shift basis

Actual Production

Pharmaceutical Formulations

 

 

 

Tablets

000 Nos.

565200

646677

Liquids

Lts.

1879500

1930622

Injections

Lts.

*

46104

Capsules

000 Nos.

*

24726

Ointments

Kgs.

*

12277

Creams

Kgs.

*

61619

Granules

Kgs.

*

308432

 

 

GENERAL INFORMATION

 

No. of Employees :

Information decline by the management

 

 

Bankers :

Bank of Baroda, Rua De Ormuz, Panaji - 403001, Goa, India

Bank of Baroda, Opposite Azad Maidan, Post Box No. 236, Panaji-403001, Goa, India

 

 

Facilities :

Secured Loan

31.03.2013

(Rs. in Millions)

31.03.2012

(Rs. in Millions)

Short-term borrowings

 

 

Working capital loans from banks

200.834

245.761

Foreign currency term loans from banks

0.000

12.699

Total

200.834

258.460

 

 

 

Banking Relations :

 

 

 

Auditors :

 

Name :

Y.N. Upadhyaya and Company

Chartered Accountants

Address :

F - 12, SOUZA TOWERS, Panaji-403001, Goa, India

PAN N Income-tax PAN of auditor or auditor's firm :

AAEPU8189N

 

 

Associates/Subsidiaries:

  • Indi Pharma Private Limited, India [U24232GA1984PTC000556]
  • Wallace Laboratories Private Limited, India

 [U33112GA1996PTC002077]

  • Wallace Medi Pharma Private Limited, India

 [U24232GA1998PTC002526]

  • Wallace Estate Private Limited, India [U70200GA1996PTC002078]
  • Wallace Medinova Private Limited, India [U52311GA1997PTC002273]
  • Wallace USA,LLC.

 

 

Other Entities In which significant influence is exercised by Key Management Personnel:

  • Prateek Menezes Memorial Foundation - Trust
  • Maria Crescencia Menezes Memorial Educational Trust - Trust
  • Laxmi Devi Business Enterprises - Partnership Firm
  • Elvina Enterprises - Partnership Firm
  • Cosme Matias Menezes Memorial Trust -Trust
  • Pascoal and Maria Menezes Benevolence Foundation - Trust
  • Ace Packers - Partnership Firm

 

 

CAPITAL STRUCTURE

 

As on 31.03.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

5250000

Equity Shares

Rs.10/- each

Rs.52.500 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

5145000

Equity Shares

Rs.10/- each

Rs.51.450 Millions

 

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

31.03.2013

31.03.2012

31.03.2011

 

 

 

 

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

51.450

51.450

51.450

(b) Reserves & Surplus

1052.836

1006.701

838.812

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

1104.286

1058.151

890.262

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

0.000

0.000

12.699

(b) Deferred tax liabilities (Net)

5.215

0.407

1.530

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

84.063

73.199

66.090

Total Non-current Liabilities (3)

89.278

73.606

80.319

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

287.755

344.881

371.321

(b) Trade payables

83.084

84.494

84.605

(c) Other current liabilities

169.228

134.848

168.003

(d) Short-term provisions

95.877

60.404

30.130

Total Current Liabilities (4)

635.944

624.627

654.059

 

 

 

 

TOTAL

1829.508

1756.384

1624.640

 

 

 

 

II.          ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

414.918

422.594

430.567

(ii) Intangible Assets

2.116

1.861

1.466

(iii) Capital work-in-progress

1.666

0.000

1.811

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

452.832

447.915

405.434

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

127.452

98.074

48.699

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

998.984

970.444

887.977

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

378.831

363.697

315.894

(c) Trade receivables

248.286

226.714

199.916

(d) Cash and cash equivalents

73.108

74.324

61.121

(e) Short-term loans and advances

130.299

121.205

159.732

(f) Other current assets

0.000

0.000

0.000

Total Current Assets

830.524

785.940

736.663

 

 

 

 

TOTAL

1829.508

1756.384

1624.640

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2013

31.03.2012

31.03.2011

 

SALES

 

 

 

 

Revenue from Operations

2661.752

2322.044

2147.113

 

Other Income

NA

NA

NA

 

TOTAL

NA

NA

NA

 

 

 

 

 

Less

EXPENSES

NA

NA

NA

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

70.421

168.101

204.778

 

 

 

 

 

Less

TAX

12.247

0.212

-1.169

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX 

58.174

167.889

205.947

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

F.O.B. Value of Exports

65.624

42.721

25.552

 

Exchange Gain

0.078

0.000

1.638

 

TOTAL EARNINGS

65.702

42.721

27.190

 

 

 

 

 

 

IMPORTS

 

 

 

 

Raw Materials

245.466

230.745

184.567

 

TOTAL IMPORTS

245.466

230.745

184.567

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

11.31

32.63

400.29

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2013

31.03.2012

31.03.2011

Return on Total Assets

(PBT/Total Assets}

(%)

5.12

12.85

16.82

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.06

0.16

0.23

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

0.26

0.33

0.43

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.31

1.26

1.13

 

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Share Capital

51.450

51.450

51.450

Reserves & Surplus

838.812

1006.701

1052.836

Net worth

890.262

1058.151

1104.286

 

 

 

 

long-term borrowings

12.699

0.000

0.000

Short term borrowings

371.321

344.881

287.755

Total borrowings

384.020

344.881

287.755

Debt/Equity ratio

0.431

0.326

0.261

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Revenue from Operations

2147.113

2322.044

2661.752

 

 

8.147

14.630

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Revenue from Operations

2147.113

2322.044

2661.752

Profit

205.947

167.889

58.174

 

9.59%

7.23%

2.19%

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

CURRENT MATURITIES OF LONG-TERM DEBT DETAILS: NOT AVAILABLE

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

Yes

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

LITIGATION DETAILS

 

CASE DETAILS

 

BENCH:-BOMBAY

Lodging No.:-

SL/2595/2012

Filing Date:-

11/10/2012

Reg. No.:-

S/2449/2012

Reg. Date:-

18/10/2012

 

 

 

 

Petitioner:-

GLAXO SMITHKLINE PHARMACEUTICALS LTD.

Respondent:-

WALLACE PHARMACEUTICALS PVT. LTD.

 

 

 

Petn.Adv.:-

CRAWFORD BAYLEY AND COMPANY (11491)

Resp.Adv.:-

JERONE JOHNSON (I8172)

 

 

 

District:-

MUMBAI

 

 

 

 

Bench:-

SINGLE

 

 

 

 

Status:-

Pre-Admission

Category:-

SUIT (TRADE MARK)

 

 

 

Last Date:-

18/07/2014

Stage:-

FOR ADMISSION/DENIAL OF DOCUMENTS

 

 

 

Last Coram:-

HON'BLE SHRI JUSTICE G.S. PATEL

 

 

 

 

Act :-

Trade & Merchandise Act 1958

 

 

OPERATIONS:

 

The Revenue from Operations for the year under consideration having amounted to Rs.2661.752 Millions as compared to Rs.2322.044 Millions achieved for the year ended 31st March, 2012. The Company realized a profit before tax of Rs.70.421 Millions as compared to Rs.168.101 Millions for the year ended 31st March, 2012.

 

CORPORATE INFORMATION:

 

Subject is a private limited company registered in India and incorporated under the provisions of the Companies Act, 1956. The company is engaged in the manufacturing and selling of medicinal preparations. The company caters to both domestic and international markets.

 

UNSECURED LOAN

 

PARTICULARS

31.03.2013

(Rs. in Millions)

31.03.2012

(Rs. in Millions)

Short-term borrowings

 

 

Loans and advances from related parties

86.921

86.421

Total

86.921

86.421

 

 

INDEX OF CHARGES

 

S.NO.

CHARGE ID

DATE OF CHARGE CREATION/MODIFICATION

CHARGE AMOUNT SECURED

CHARGE HOLDER

ADDRESS

SERVICE REQUEST NUMBER (SRN)

1

90065534

31/03/1999

20,000,000.00

BANK OF BARODA

RUA -DE ORMUZ, PANAJI, GOA, INDIA

-

2

80001351

21/01/1999

1,850,000.00

BANK OF BARODA

OPP AZAD MAIDAN, PANJI, GOA - 403001, INDIA

-

3

90065533

21/01/1999

2,000,000.00

BANK OF BARODA

RUA -DE ORMUZ, PANAJI, GOA, INDIA

-

4

90064754

28/12/1999 *

193,500,000.00

BANK OF BARODA

RUA -DE ORMUZ, PANAJI, GOA, INDIA

-

5

90064987

29/06/1997

161,500,000.00

BANK OF BARODA

PANAJI, GOA, GOA, INDIA

-

6

90065495

20/03/2007 *

365,000,000.00

BANK OF BARODA

OPP. AZAD MAIDAN, POST BOX NO.236, PANAJI, GOA - 403001, INDIA

-

7

80001352

25/06/1997

2,550,000.00

BANK OF BARODA

OPP AZAD MAIDAN, PANJI, GOA - 400001, INDIA

-

8

90064745

28/12/1999 *

161,500,000.00

BANK OF BARODA

RUA -DE ORMUZ, PANAJI, GOA, INDIA

-

9

90064986

21/01/1999 *

161,500,000.00

BANK OF BARODA

RUA -DE ORMUZ, PANAJI, GOA, INDIA

-

10

90065446

29/04/1997 *

960,000.00

BANK OF BARODA

PANAJI, GOA, GOA, INDIA

-

 

* Date of charge modification

 

FIXED ASSETS

 

Tangible assets

 

  • Land
  • Buildings
  • Plant and equipment
  • Furniture and fixtures
  • Vehicles

 

Intangible assets

 

  • Computer software
  • Copyrights

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.60.83

UK Pound

1

Rs.98.15

Euro

1

Rs.78.66

 

 

INFORMATION DETAILS

 

Information Gathered by :

GYT

 

 

Analysis Done by :

RAS

 

 

Report Prepared by :

KVT


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

4

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

6

--CREDIT LINES

1~10

6

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

YES

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

49

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.